Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Company Summary
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. Its lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus for wound healing indications. Cambium Bio Limited is based in Paddington, Australia.
Health Care
Biotechnology
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.